alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › economic

economic

265 studies tagged economic, dated 1989-11-10 to 2026-10-28. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. The Contribution of Routinely Collected Clinical Data to Dementia Identification in Primary Care: A Cross-Sectional Study 2026-10-28
  2. Racial Differences and Temporal Trends in Parkinson’s and Alzheimer’s Disease-Related 2026-10-24
  3. Prognostic heterogeneity within cognitive stages: a nationwide cohort study of everyday functional difficulties and mortality in 202,508 older adults 2026-10-23

Studies

265 studies carry this tag.

Date range

1989 to 2026

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 38
  • Journal of the American Geriatrics Society 21
  • medRxiv 19
  • Journal of Alzheimer's disease : JAD 15
  • Research Square 15

104 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. The Contribution of Routinely Collected Clinical Data to Dementia Identification in Primary Care: A Cross-Sectional Study

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Research Square 2026-10-28 Getting a diagnosis

    Sociodemographic and clinical variables routinely recorded in PC EHRs may contribute to dementia identification.

  2. Racial Differences and Temporal Trends in Parkinson’s and Alzheimer’s Disease-Related

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2026-10-24 Disparities

    Recorded PD-related mortality was lower among Black than White adults, whereas AD-related mortality showed no statistically significant racial difference.

  3. Prognostic heterogeneity within cognitive stages: a nationwide cohort study of everyday functional difficulties and mortality in 202,508 older adults

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Research Square 2026-10-23 Risk factors

    Cognitive staging and everyday function are not interchangeable.

  4. Patient-Reported Shared Decision-Making and Documented Advance Care Planning Among Adults With Alzheimer’s Disease and Related Dementias

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2026-10-19 End-of-life care

    Among adults with ADRD, high SDM was associated with greater ACP prevalence in unadjusted analyses, although the fully adjusted association was not statistically significant.

  5. Research attitudes mediate the association between educational attainment and willingness to participate in Alzheimer’s disease research beyond Alzheimer’s disease knowledge

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2026-10-15 Prevention trials

    STRUCTURED ABSTRACT INTRODUCTION This study examined the extent to which educational attainment, Alzheimer’s disease (AD) knowledge, and research attitudes are associated with willingness to participate in AD research, and whether AD knowledge and research attitudes mediate associations between educational attainment and willingness to participate.

  6. The Effect of Noncontingent Monetary Incentives in Recruitment Letters on Research Enrollment of Alzheimer’s Disease and Related Dementia Caregiving Dyads: A Study Within a Trial (SWAT) Randomized Controlled Trial

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Research Square 2026-10-14 Clinical trials

    In this trial, $5 and $25 noncontingent monetary incentives included in mailed recruitment letters did not produce a detectable improvement in response among ADRD caregiving dyads.

  7. The Role and Future Potential of Radio, Podcasts, and YouTube in Influencing Awareness and Policy on Neurodegenerative Diseases in the Arab Gulf: A Focus on Oman, Qatar, UAE, and Saudi Arabia

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Preprints.org 2026-10-14 Risk factors

    The increasing prevalence of neurodegenerative diseases (NDs), especially Alzheimer's and Parkinson's, is a major public health concern in the Gulf countries (GCs) due to the rapid increase in life expectancy and population aging.

  8. Enhancing Neurodegeneration Awareness and Care for the Elderly in Saudi Arabia, UAE, Oman, and Qatar: Challenges, Policy Gaps, and Future Directions

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Preprints.org 2026-10-13 How common it is

    GCC countries are experiencing a rapid demographic transition.

  9. The transition to retirement and dementia risk: An application of sequence analysis

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2026-10-09 Long-term cohort studies

    Retirement timing alone showed limited association with later-life dementia risk, whereas sustained part-time employment and disability-related trajectories were more strongly associated with dementia risk.

  10. Mobile Clinics for Brain Health Equity: A Feasibility Study of Dementia Risk Reduction in Underserved Communities

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Research Square 2026-09-30 Prevention trials

    Recruitment (88.0%) and protocol fidelity (100%) met or exceeded prespecified progression criteria, whereas retention and follow-up data availability were 59.1% (13/22), slightly below the predefined 60% criterion.

  11. Clinically Recognised Alcohol Use Disorder and Risk of Dementia Subtypes in 1.3 Million Women: A Prospective Cohort Study

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2026-09-29 Prevention and risk

    Among 1,288,359 women, 20,070 with AUD were matched to 100,339 controls.

  12. Changing Landscape of Alzheimer’s Disease Mortality in the United States (1979– 2023): A CDC WONDER Analysis of Epidemiological Shifts, Disparities and ARIMA-Based Projections to 2050

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Research Square 2026-09-17 How common it is

    Between 1979 and 2023, AD caused 2,430,795 deaths in U.S. adults.

  13. Association between urban green space coverage and incident Alzheimer’s disease among older adults in metropolitan South Korea: a population-based retrospective cohort study

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Research Square 2026-09-14 Risk factors

    Higher UGS coverage was associated with a lower risk of incident AD among older adults in urban South Korea.

  14. Alzheimer disease risk estimates lose clinical calibration across study phases despite useful patient ranking

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Research Square 2026-09-04 Long-term cohort studies

    Risk prediction in Alzheimer disease can guide follow-up, biomarker testing, trial referral, and prognostic counseling.

  15. Modifiable Risk Factors for Dementia across the Europe: regional comparative studyusing SHARE data

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Research Square 2026-09-04 Risk factors

    Our findings reveal marked geographic variation in dementia risk factors, highlighting the need for region-specific prevention strategies.

  16. Association between Internet Use for Health Information and Self-reported Alzheimer’s Disease Diagnosis among Older Adults in the United States: Racial and Gender Disparities

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Research Square 2026-08-27 Health systems and care delivery

    Internet use for health information was significantly associated with Alzheimer’s disease diagnosis.

  17. Retrospective Forecasting and Long-Term Projection of Alzheimer’s Disease Spreading

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Research Square 2026-08-20 How common it is

    The dynamics of Alzheimer’s disease spread in aging groups of population are described using an Inflow-Outflow Model.

  18. The prognostic significance of distinct psychosis symptom profiles in dementia: A cohort study using linked electronic health records

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Research Square 2026-08-05 Health systems and care delivery

    The prognostic significance of psychosis in dementia differs by symptom profile.

  19. Cost-effectiveness of amyloid-targeting therapies in a memory clinic population; a simulation study

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2026-08-02 Treatments

    The cost-effectiveness of ATTs is strongly influenced by the waning of the treatment effect.

  20. Eligibility for shingles vaccination and hospital-coded dementia in England and Wales: a regression discontinuity analysis in England

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2026-07-21 Getting a diagnosis

    We used the September 2013 age-based rollout of the live-attenuated shingles vaccine in England as a natural experiment to estimate the effect of vaccine eligibility on shingles and dementia diagnoses in linked hospital records.

  21. Death in People with Down syndrome: Mortality statistics and novel predictors in US Medicaid and Medicare enrolled adults

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2026-07-20 Costs and economics

    People with Down syndrome have higher age-specific mortality rates compared to the general population as well as peers with other intellectual and developmental disabilities.

  22. Chart review and genetic validation of electronic medical record dementia diagnoses in VA: The impact of CMS data

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2026-07-17 Costs and economics

    We recommend using a broad (ADRD) algorithm without CMS or medication data, particularly for epidemiological studies or a strict AD algorithm including CMS and medication cases for genetic discovery of late-onset AD associations in VA EMR, and a strict AD algorithm without CMS data for applications focused solely on AD and sensitive to misspecification.

  23. Functional–behavioral patterns associated with care-related risk in hospitalized patients with Alzheimer’s disease: a real-world clustering analysis

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Research Square 2026-06-30 Clinical safety

    Functional–behavioral subtypes can be identified in hospitalized AD patients, supporting multidimensional risk stratification and individualized care planning.

  24. Mapping U.S. POINTER Cognitive-Slope Gains Onto Predicted Clinical Progression: An External-Cohort Translation Analysis With Exploratory Economic Thresholds

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2026-05-20 Costs and economics

    POINTER reported a modest structured-versus-self-guided difference in the annual rate of global cognitive change.

  25. A Transferable Health Economic Evaluation Framework for Alzheimer’s Disease-Modifying Therapies

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Research Square 2026-05-05 Costs and economics

    Base-case incremental cost-effectiveness ratios (ICERs) for lecanemab versus standard of care were €296,506 per QALY gained, and €371,299 per QALY for donanemab, from the HSE payer perspective under HIQA guidelines.

  26. Disease Burden and Direct Health-Care Spending on Brain Conditions in Switzerland: Findings from the Global Burden of Disease 2023 Study for the Implementation of the Swiss Brain Health Plan

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2026-05-03 Costs and economics

    In fixed-effects panel models that accounted for spending persistence, lagged DALYs were not statistically associated with subsequent spending.

  27. The Alzheimer’s disease Burden in China (ABC) study: protocol for a nationwide multicentre cross-sectional and prospective cohort study

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2026-05-01 Costs and economics

    Previous studies have shown that AD-related costs are mainly driven by long-term informal care.

  28. A Simulation-Based Discrete Choice Experiment Framework for Alzheimer’s Disease-Modifying Therapy Implementation: Methodology and Interactive Decision Support Tool

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Research Square 2026-04-14 Treatments

    Under calibrated simulation parameters, slowing of cognitive decline emerged as the most important attribute (relative importance 25.7%), followed by annual cost (17.6%), ARIA risk (15.4%), and travel to treatment centre (13.0%).

  29. PREFER-DMT: A Discrete Choice Experiment Framework for Eliciting Stakeholder Preferences on Disease-Modifying Therapy Implementation in European Healthcare Systems

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Research Square 2026-04-14 Treatments

    Simulation-based validation demonstrates the framework’s analytical capability.

  30. Effectiveness of a Socially Implemented Cognitive Decline Prevention Program: A Retrospective Observational Study

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2026-04-09 Health systems and care delivery

    The multifactorial interventions implemented in community settings showed no effect on dementia onset or health outcomes.

  31. Assessing the risk of early-onset dementia within 5 years of cancer diagnosis

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2026-02-15 Digital health tools

    EOD incidence peaked at 4-5% among beneficiaries with and without cancer.

  32. Incidence of dementia after a recent cancer diagnosis among people with HIV

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2026-02-15 Digital health tools

    Dementia risk may be increased among people with HIV with certain cancers, including AIDS-defining cancers.

  33. Performance of ICD10 Code-Based Dementia Case Definition in the Health and Retirement Study

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2026-01-13 Costs and economics

    STRUCTURED ABSTRACT INTRODUCTION The Dementia DataHub (DDH) reports U.S. dementia prevalence and incidence from Medicare data.

  34. Prevalence and outcomes of recorded dementia vary by data source: a population cohort study of 133,407 older adults

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2026-01-09 Clinical safety

    Dementia is variably recorded across routine datasets, and the setting in which dementia is first recorded identifies groups with markedly different prognosis.

  35. The Societal Cost of Alzheimer’s Disease depends on the Diagnosis Timing

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2026-01-08 Costs and economics

    Earlier diagnosis increases total expenditures but improves care and cost allocation.

  36. Budget Impact Analysis of Disease-Modifying Therapies for Alzheimer’s Disease in Ireland: A Model-Based Analysis

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2025-12-30 Treatments

    These therapies require complex diagnostic workup and safety monitoring, raising significant budget impact concerns for healthcare payers.

  37. Cognitive screening biases in a secondary prevention Alzheimer’s disease clinical trial

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2025-12-04 Treatments

    Biases in cognitive/functional screening tests may disproportionately exclude ethnoracial minorities in AD prevention trials.

  38. Long-term cost-effectiveness of a more accurate diagnostic work-up for dementia

    ✓ Peer-reviewed alzhub usefulness score 59 out of 100. Alzheimer's & dementia (Amsterdam, Netherlands) 2025-11-04 Costs and economics

    PET participants lived longer in community (0.26 years, 95% confidence interval [CI]: 0.05 to 0.45) and overall (0.15, CI: 0.02 to 0.27), but did not have statistically different health insurance (€703, CI: -3974 to 5045) or total costs including institutionalization (-€8258, CI: -20,622 to 3377).

  39. Causal effect of conventional anti-dementia drugs on economic burden: an orthogonal double/debiased machine learning approach

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. BMC geriatrics 2025-08-25 Costs and economics

    A total of 12,764,487 weighted older adults with ADRD were included, with 34.60% of them using anti-dementia drugs.

  40. Economic Impact of Dementia After Kidney Transplantation: A Matched Cohort Analysis

    ✓ Peer-reviewed alzhub usefulness score 73 out of 100. Clinical transplantation 2025-06 Costs and economics

    Dementia was diagnosed at a mean of 5.1 ± 3.4 years post-KTx.

  41. Dementia Diagnosis Unawareness and Caregiver Burden in a Multi-ethnic Cohort

    ✓ Peer-reviewed alzhub usefulness score 70 out of 100. Journal of general internal medicine 2025-01-14 Caregiving

    Eighty-one percent of eligible participants were not aware of a dementia diagnosis.

  42. Pathways to Racial/Ethnic Inequalities in Dementia

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Annual review of clinical psychology 2025-01-13 Disparities

    Individuals from minoritized racial/ethnic groups face a disproportionate burden of Alzheimer's disease and related dementias.

  43. The African American Dementia and Aging Project: an Oregon-based longitudinal study

    ✓ Peer-reviewed alzhub usefulness score 68 out of 100. Frontiers in dementia 2024-11-18 Disparities

    AADAPt participants had risk factors for developing dementia in future, such as hypertension and hyperlipidemia, but also reported protective factors such as high social engagement.

  44. Healthcare Resource Utilization Among Patients With Agitation in Alzheimer Dementia

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. Journal of health economics and outcomes research 2024-10-29 Costs and economics

    Of 2 684 704 Fee-for-Service patients with Alzheimer dementia, 769 141 met all inclusion criteria; among these, 281 042 (36.5%) had agitation.

  45. Patterns of Migration Following Dementia Diagnosis

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. JAMA network open 2024-10-01 Costs and economics

    The sample included 1 626 127 Medicare beneficiaries (mean [SD] age, 80.1 [8.0] years; 922 194 women [56.7%]) who received diagnoses of the 4 conditions in 2016.

  46. The global macroeconomic burden of Alzheimer's disease and other dementias: estimates and projections for 152 countries or territories

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. The Lancet. Global health 2024-09-01 Caregiving

    ADODs will cost the world economy 14 513 billion international dollars (INT$, measured in the base year 2020; 95% uncertainty interval [UI] 12 106-17 778) from 2020 to 2050, equivalent to 0·421% (95% UI 0·351-0·515) of annual global GDP.

  47. Racial and ethnic disparities in potentially inappropriate medication use in patients with dementia

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Journal of the American Geriatrics Society 2024-08-21 Disparities

    Compared to White participants, Black, Hispanic, and Asian participants reported taking fewer total medications (incidence rate ratio [IRR] ± standard error[SE] = 0.903 ± 0.017, 0.875 ± 0.021, and 0.912 ± 0.041, respectively, all p < 0.01).

  48. Divergent Mortality Patterns Associated With Dementia in the United States: 1999-2020

    ✓ Peer-reviewed alzhub usefulness score 75 out of 100. The primary care companion for CNS disorders 2024-08-13 Disparities

    Among these, 85.5% were non-Hispanic (NH) white, 8% NH black, 4.34% Hispanic or Latino, 1.6% NH Asian or Pacific Islander, and 0.3% NH American Indian or Alaska Native adults.

  49. Reasons for undergoing amyloid imaging among diverse enrollees in the A4 study

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2024-07-23 Disparities

    Compared to non-Hispanic or Latino (NH) White participants, Hispanic or Latino (3.52 points, 95% confidence interval [CI]: [2.61, 4.42]); NH Asian (2.97 points, 95% CI: [1.71, 4.22]); and NH Black participants (2.79 points, 95% CI: [1.96, 3.63]) participants demonstrated higher levels of endorsement of the VPAI items at baseline.

  50. Racial/ethnic differences in neuropsychiatric disturbances associated with incident dementia

    ✓ Peer-reviewed alzhub usefulness score 63 out of 100. Alzheimer's & dementia (Amsterdam, Netherlands) 2024-07-05 Disparities

    NPS were present in 95% in at least one time point.

From across this tag

9 of the 265 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 9. The same 9 appear here every time.

All topic tags with their study counts